You can however send us an e-mail directly to providing all information requested below in the message body of your e-mail.
Check real-time insurance approval status by simply logging into the OmniSource e-Prescribing Platform
To find a designated OmniSource Case Manager, click here.
Omnitrope is a recombinant human growth hormone indicated for:
IMPORTANT SAFETY INFORMATION
Who should not take Omnitrope® (somatropin [rDNA origin] injection)?
Omnitrope should not be used in children and adults with any of the following medical conditions because serious side effects can occur:
Omnitrope should also not be used in children who have completed growth.
What should patients tell their doctor before taking Omnitrope?
Patients should tell their doctor about their medical and family history, treatment use and past and existing medical conditions, such as but not limited to the following:
What are the most common side effects of Omnitrope?
Other possible side effects of Omnitrope are:
To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.